Studies
Clinical trials represent the crucial interface between innovative cancer research and successful therapy. They give patients direct access to the latest therapeutic developments and provide the possibility of promptly benefiting from current research findings. You can find information for patients about clinical trials in the "For Patients" section. Around 500 oncological clinical studies and Investigator Initiated Trials (IITs) are currently conducted at the National Center for Tumor Diseases (NCT) in Heidelberg.
Clinical studies by tumor disease or area can be found here:
Register for oncology studies
On the internet platform QuickQueck you will find all active studies of the NCT Heidelberg as well as other ongoing oncological studies recruiting in Germany. The platform enables physicians and patients to search quickly and specifically.
To make it easier for you to find a suitable study in your area, you will find an overview of the oncology studies at our cooperation partner Mannheim Cancer Center of the University Medical Center Mannheim (UMM) here.
Study Requests and Feasibility Assessment
Sponsors, CROs, research networks, etc., please send your study request directly to the appropriate study team, according to the e-mail contact list below. You will receive prompt feedback, once the feasibility of your study request has been assessed. This flowchart shows our standard workflow for study/feasibility requests.
Study Team | Contact Person for Study/Feasibility Requests
|
CUP (Carcinoma of Unknown Primary) | PD Dr. Tilmann Bochtler tilmann.bochtler(at)med.uni-heidelberg.de Prof. Dr. Alwin Krämer Alwin.Kraemer(at)med.uni-heidelberg.de |
Cross-Entity/Basket
| a) Prof. Dr. Guy Ungerechts b) Prof. Dr. Richard Schlenk |
Gastrointestinal Tumors
| a) Prof. Dr. Georg Martin Haag b) PD Dr. med. Bruno Christian Köhler c) Prof. Dr. Dr. Christoph Springfeld |
Gynecological Tumors/Breast Cancer | Prof. Dr. Andreas Schneeweiss andreas.schneeweiss(at)med.uni-heidelberg.de |
Hematological Neoplasms | Studienportal Innere Medizin V studienportal.med5(at)med.uni-heidelberg.de |
Skin Tumors | Prof. Dr. Jessica Hassel jessica.hassel(at)med.uni-heidelberg.de |
Head and Neck Tumors | Dr. Sebastian Dieter sebastian.dieter(at)med.uni-heidelberg.de |
Neuroendocrine Tumors | PD Dr. Leonidas Apostolidis leonidas.apostolidis(at)med.uni-heidelberg.de |
Brain/CNS Tumors | Dr. Antje Wick antje.wick(at)med.uni-heidelberg.de |
Phase 1 Studies | Prof. Dr. Guy Ungerechts guy.ungerechts(at)nct-heidelberg.de |
Prevention | Prof. Dr. Hermann Brenner h.brenner(at)dkfz.de |
Radiooncology | Prof. Dr. Dr. Jürgen Debus studien.radonk(at)med.uni-heidelberg.de |
Sarcoma | Prof. Dr. Gerlinde Egerer Gerlinde.Egerer(at)med.uni-heidelberg.de PD Dr. Leonidas Apostolidis leonidas.apostolidis(at)med.uni-heidelberg.de |
Supportive Therapy | NCT Studienportal studienportal.nct(at)med.uni-heidelberg.de |
Thoracic Tumors | Prof. Dr. Michael Thomas Studienkoordination-Onkologie.THOR(at)med.uni-heidelberg.de |
Urogenital Tumors | PD Dr. Stefanie Zschäbitz stefanie.zschaebitz(at)med.uni-heidelberg.de |